8th European Mucosal Immunology Group (EMIG) meeting

On behalf of the organising committee, I would like to invite you to the 8th European Mucosal Immunology Group (EMIG) meeting which will take place in Dublin, from October 10th – 13th 2012.

EMIG-2012 brings together scientists and clinicians in the field of mucosal immunology with a particular focus on mucosal innate and adaptive immunity and the clinical implications of immune dysregulation including Inflammatory Bowel Disease (IBD) and Coeliac Disease. The topics of the meeting will include bacteria-host interactions, mucosal antigen presenting cells, regulation of inflammatory responses and mucosal vaccination. There will be a particular emphasis on current and future therapeutic approaches.
+ show speakers and program
Prof Per Brandtzaeg – University of Oslo, Norway

Professor Per Brandtzaeg obtained his postgraduate training in microbiology, immunology and pathology at the MedicalCenter, Univ.of Alabamaat Birmingham, AL, USA, and received his PhD in immunology at the Univ.of Oslo. He is the former Head of the Faculty Division, Rikshospitalet, Oslo University Hospital, and the founder of the Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), Department of Pathology, which is devoted to research on mucosal immunity and partner of the Centre for Immune Regulation,University of Oslo.

Prof Andrea Cerutti – Catalan Institute for Research and Advanced Studies. Spain

Dr. Andrea Cerutti took his M.D. degree and completed residency training in hematology at the University of Padua (Italy). After postdoctoral training in immunology, he was appointed Assistant Professor and then Associate Professor of Pathology at Weill Medical College of Cornell University (New York). In 2009 he joined Mount Sinai School of Medicine (New York) as Professor of Medicine. In the same year, he also became ICREA Research Professor at IMIM-Hospital del Mar in Barcelona (Spain). He studies the regulation of antibody production and diversification in B cells.

Prof Stefan Kauffman – Max Planck institute for Infection Biology, Germany

Stefan H.E. Kaufmann is Founding Director of the Max Planck Institute for Infection Biology,Berlin, where he heads the Department of Immunology and Professor for Microbiology and Immunology at the Charité University Clinics Berlin. He is Past President and Honorary Member of the German Society for Immunology, Past President of the European Federation of Immunological Societies and current President of the International Union of Immunological Societies.

Prof Denise Kelly – The University of Aberdeen, Scotland

Professor Denise Kelly has a strong research interest in gut microbiology and immunology with 20 years post-doctoral experience. She obtained her BSc and PhD from Queens’s University Belfast. Her first post-doctoral research appointment was with Nestle in Lausanne, Switzerland. She then moved to the Rowett Institute of Nutrition & Health, University of Aberdeen and is now Head of the Gut Immunology Group. Her main research interests are in gut microbiota and immunity and in the mechanisms of bacterial-induced inflammation and regulation. Recent achievements include appointment to the Editorial board of the US Journal Gut Microbes, UK partner in an EU-funded ITN project and the formation of a new Biotech company GT Biologics Ltd.

Prof. Frits Koning- Leiden University Medical Centre, The Netherlands

Prof. Frits Koning is a Professor of Immunology at the Leiden University Medical Centre, Leiden, The Netherlands. He is an internationally recognized expert in the field of HLA-associated diseases, in particular celiac disease. He is the chairman of the Scientific Advisory Board of the Leiden Univesrity Medical Centre and CEO of the Dutch based Celiac Disease Consortium which performs basic and translational research in the area of celiac disease. He participates in national and international projects on CD. His group identified gluten peptides that are recognised by gluten-specific T cells isolated from the small intestine of CD patients. Moreover, he has elucidated the specificity of tissue transglutaminase, an enzyme that is involved in gluten toxicity. His group has developed an antibody-based test to screen foods for the presence of toxic gluten peptides and they are active in translational research aimed at the development of novel therapies for celiac disease patients. He authored over 160 peer reviewed papers. In 2010 he was awarded the Rank Prize for Nutrition (London,UK). In 2011 he received the Warren Prize for Excellence in Celiac Disease Research (La Jolla,USA).

Prof Olivier Lantz – Institut Curie Paris, France

Olivier Lantz is an MD/PhD, heads the clinical immunology laboratory and is group leader in the Immunology department (INSERM U932) both at Institut Curie in Paris. His main scientific achievements relate to evolutionarily conserved invariant T cell subsets, NKT and MAIT cells. His group has contributed to most of what is currently known on MAIT cells. The group also studies basic questions regarding CD4 T-cell physiology and develops new mouse tumor models to study the interactions between the immune system and tumors that express nominal antigen.

Prof Allan Mowat – University of Glasgow, Scotland

Allan Mowat is Professor of Mucosal Immunology at the University of Glasgow and has been working on the regulation of immune responses in the intestine for more than 30 years. Current work in his laboratory focusses on the nature of macrophages and dendrtiic cells in the colon and small intestine, exploring how these cells contribute to maintaining local homeostasis and attempting to understand how the populations change in the context of inflammation or protective immunity.

Prof Luke O’Neill – Trinity College Dublin, Ireland

Professor Luke O’Neill was appointed to the Chair of Biochemistry at Trinity College Dublin in 2008, where he leads the Inflammation Research Group. He is also Academic Director of the Trinity Biomedical Sciences Institute. He has a PhD in Pharmacology from the University of London and carried out Post-Doctoral research at the Strangeways Laboratory in Cambridge. He has won numerous awards for his research, notably the Royal Irish Academy Medal for Biochemistry, The Irish Society for Immunology medal, the Royal Dublin Society/ Irish Times Boyle medal for Scientific Excellence and the Science Foundation Ireland Researcher of the Year Award 2009. He was elected a member of EMBO in 2005. He is a co-founder and director of Opsona Therapeutics. In 2008 he was appointed Chair of the Immunity and Infection panel of the European Research Council. His research is in the area of the molecular basis to inflammatory diseases, with a particular interest in pro-inflammatory cytokines and Toll-like receptors. He has published over 200 papers and reviews on his research, in journals such as Nature, Science, Cell, Nature Immunology, Nature Medicine, Nature Genetics and PNAS. He is on the editorial boards of 6 journals, including the Journal of Biological Chemistry and Trends in Immunology. He is also on the Board of Reviewing Editors for Science, covering Innate Immunity.

Prof. Dr. Maria Rescigno - European Institute of Oncology, Milan

Maria Rescigno graduated in Biology in 1990 at the University of Milan. From 1991 to 1994 she worked at the University of Cambridge, UK, in the Department of Biochemistry, as a visiting scholar. From 1995 to 1999, she worked at the National Research Council of Milan where she received her PhD in Pharmacology and toxicology in 1999. From 1999 to 2001 she worked at the University of Milano-Bicocca where she specialized in Applied Biotechnology. Since 2001 she is the director of the Dendritic cell biology and immunotherapy Unit at the Department of Experimental Oncology at the European Institute of oncology. She was the first to show that dendritic cells in the gut actively participate to bacterial uptake. Her major field of interest is the development of new immunotherapy strategies to fight cancer. She authored more than 100 publications in high impact journals including Nature Immunol, Immunity, J. Exp. Med., Science TM. She was nominated EMBO young investigator in 2007. Since 2008 she is visiting professor at the University of Oslo. In 2011 Maria Rescigno won the Avon prize as ‘Woman symbol of the city of Milan’ and was elected EMBO member.

Prof Fergus Shanahan – University College Cork, Ireland

Prof. Fergus Shanahan is Professor and Chair of the Department of Medicine at University College Cork, National University of Ireland, and Director of the Alimentary Pharmabiotic Centre, a research centre funded by Science FoundationIreland which investigates host-microbe interactions in the gut. After medical residency inDublin, he trained in clinical immunology atMcMaster University,Canada and in gastroenterology at theUniversity ofCalifornia,Los Angeles. His interests are broad including most things that affect the human experience. He has published over 350 scientific articles and several books in mucosal immunology, IBD, and the gut microbiota.

Dr Holm Uhlig – University of Oxford, UK

Dr. Holm Uhlig is a Senior Clinical Research Fellow in Paediatric Gastroenterology and Mucosal Immunology at the Translational Gastroenterology Unit, University of Oxford. He completed medical residency in pediatrics and pediatric gastroenterology at the University of Leipzig (Germany) and obtained a DPhil in mucosal immunology at the Sir William Dunn School of Pathology in Oxford (UK). Holm is interested in regulation of immune responses in the intestine. Current studies involve the genetic analysis of children with early onset of IBD and functional analysis of those defects.

10 Oct - 13 Oct 2012

meeting website